CD8A and neoplasm: Third, succinate also inhibits TIL anti-tumor activity: Succinate is taken up by MCT1 in CD4+ and CD8+ T cells, and this accumulated succinate blocks metabolic flux through the TCA cycle by inhibiting the enzyme succinyl CoA synthetase (SUCLA2) [232].